Prevenar 13® use extended to adults in US and Canada

The vaccine is used to reduce the risk of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in young children and now older adults.

In New Zealand Prevenar 13® is recommended for children with conditions that increase their risk of invasive pneumococcal disease and an alternative vaccine is used for adults.